Efgartigimod Clinical Trials
5 recruitingDrug
Phase 42Phase 21Phase 31
Showing 1–5 of 5 trials
Recruiting
Phase 3
Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis
Myasthenia Gravis
Janssen Research & Development, LLC115 enrolled8 locationsNCT07217587
Recruiting
A Worldwide Pregnancy Safety Study to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to Efgartigimod During Pregnancy and/or Breastfeeding.
Myasthenia GravisCIDP - Chronic Inflammatory Demyelinating Polyneuropathy
argenx279 enrolled4 locationsNCT06299748
Recruiting
Phase 2
A Study of Efgartigimod in Patients With IgG4-Related Disease
IgG4-related Disease
Stanford University5 enrolled1 locationNCT07025330
Recruiting
Phase 4
Evaluate the Benefit of Corticoid Sparing in Elderly With Generalized AntiRAch Myasthenia Gravis Treated With IV or SC Efgartigimod
Myasthenia Gravis, Generalized
Centre Hospitalier Universitaire de Nice50 enrolled1 locationNCT07072988
Recruiting
Phase 4
Treatment of Myasthenia Gravis Exacerbation or Crisis With Efgartigimod
AChR Myasthenia GravisMyasthenia Gravis CrisisMyasthenia Gravis Exacerbations
University of Colorado, Denver20 enrolled1 locationNCT06860633